Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Bone health in chronic neurological diseases: a focus on multiple sclerosis and parkinsonian syndromes.
Increased thyroid autoimmunity among women with multiple sclerosis in the postpartum setting.
Regulation of human glia by multiple sclerosis disease modifying therapies.
Early axonal damage and progressive myelin pathology define the kinetics of CNS histopathology in a mouse model of multiple sclerosis.
Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa.
How does fingolimod (gilenya(®)) fit in the treatment algorithm for highly active relapsing-remitting multiple sclerosis?
Emerging roles of system [Formula: see text] antiporter and its inhibition in CNS disorders.
Hsp70 regulates immune response in experimental autoimmune encephalomyelitis.
Advances in the treatment of relapsing - Remitting multiple sclerosis.
Loss of retinal nerve fibre layer axons indicates white but not grey matter damage in early multiple sclerosis.
Regulation of oligodendrocyte precursor migration during development, in adulthood and in pathology.
Dark microglia: A new phenotype predominantly associated with pathological states.
Evaluation of an Online Platform for Multiple Sclerosis Research: Patient Description, Validation of Severity Scale, and Exploration of BMI Effects on Disease Course.
Everyday memory impairment, neuroradiological findings and physical disability in multiple sclerosis.
The role of the community nurse in care provision for people with multiple sclerosis.
Alemtuzumab for the treatment of relapsing-remitting multiple sclerosis.
Dermatoglyphic features in patients with multiple sclerosis.
Acute necrotizing encephalopathy (ANE1): rare autosomal-dominant disorder presenting as acute transverse myelitis.
Blind analysis: Hide results to seek the truth.
Anti-aquaporin-4 antibody-positive dorsal midbrain syndrome.
Environmental Pathology: SY09-2 MULTIPLE SCLEROSIS (MS) AND NEURODEGENERATION: CAUSE AND PATHOGENESIS IN RELATION TO ELECTROMAGNETIC FIELDS (EMF).
TNF-α-mediated anxiety in a mouse model of multiple sclerosis.
Neuro-ophthalmology update.
Female Gender and Reproductive Factors Affecting Risk, Relapses and Progression in Multiple Sclerosis.
Cell-specific effects in different immune subsets associated with SOCS1 genotypes in multiple sclerosis.
Pages
« first
‹ previous
…
383
384
385
386
387
388
389
390
391
…
next ›
last »